Pyrimidinones as Casein Kinase II (CK2) modulators
申请人:Exelixis, Inc.
公开号:US08101625B2
公开(公告)日:2012-01-24
A compound having Formula (I) or a pharmaceutically acceptable salt thereof, wherein X, R1 and R2 are defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.